chlorpromazine has been researched along with flupenthixol in 46 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (54.35) | 18.7374 |
| 1990's | 9 (19.57) | 18.2507 |
| 2000's | 4 (8.70) | 29.6817 |
| 2010's | 7 (15.22) | 24.3611 |
| 2020's | 1 (2.17) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, VS; Meltzer, HY; Paul, SM | 1 |
| Juorio, AV | 1 |
| Munday, KA; Poat, JA; Sumners, C; Woodruff, GN | 1 |
| Barnes, JL; Mee, TJ; Smith, JA | 1 |
| Carney, MW; Crow, TJ; Frith, CD; Johnstone, EC; Price, JS | 1 |
| Horn, AS; Kennard, O; Post, ML | 1 |
| Bartlett, W; Bourne, RC; Cotes, PM; Crow, TJ; Johnstone, EC | 1 |
| Miller, RJ | 1 |
| Johnson, DA; Malik, NA | 1 |
| Kelly, PH; Miller, RJ | 1 |
| Gregory, RP; Rudge, P; Smith, PT | 1 |
| Hawton, K; Reznek, L; Shepstone, B; Soper, N | 1 |
| Grosman, N | 1 |
| Matsubara, S; Meltzer, HY | 1 |
| Kehoe, R; Young, A | 1 |
| Dymock, IW; Lo, TC; Unwin, MR | 1 |
| Ardern, M; Gelder, MG; Jambor, K; Kolakowska, T; Mandelbrote, BM; Reveley, MA; Williams, AO | 1 |
| Crow, TJ; Johnson, AL; Johnstone, EC; MacMillan, JF | 1 |
| Dinan, TG | 1 |
| Barakat, S; Berkal, A; Brown, JH; McIlwraith, R | 1 |
| Nielsen, IM | 1 |
| Daus, FJ; Hansen, HA; Plantjé, JF; Stoof, JC | 1 |
| Bourne, RC; Crow, TJ; Fadhli, AA; Johnstone, EC; Owen, F | 1 |
| Matsubara, R | 1 |
| Vohra, SB | 1 |
| Szabo, CP | 1 |
| Bindl, A; Eberlein-König, B; Przybilla, B | 1 |
| Blenau, W; Marg, S; Walz, B | 1 |
| Lam, D; Patten, SB; Pringsheim, T; Tano, DS | 1 |
| Chen, YC; Chen, YW; Chu, CC; Leung, YM; Wang, JJ | 1 |
| Dold, M; Engel, RR; Leucht, S; Tardy, M | 1 |
| Osman, E; Yıldız, M | 1 |
| George, SR; Guan, HC; Laurier, LG; Ng, G; Niznik, HB; O'Dowd, BF; Seeman, P; Sunahara, RK; Torchia, J; Van Tol, HH | 1 |
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Chakrabarti, JK; Horsman, L; Hotten, TM; Pullar, IA; Tupper, DE; Wright, FC | 1 |
| Chakrabarti, JK; Fairhurst, J; Gutteridge, NJ; Horsman, L; Pullar, IA; Smith, CW; Steggles, DJ; Tupper, DE; Wright, FC | 1 |
| Bøgesø, KP | 1 |
| Emms, F; Freedman, SB; Knowles, MR; Marwood, R; McAllister, G; Patel, S; Seabrook, GR | 1 |
| Pajeva, I; Wiese, M | 1 |
| Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Brincat, JP; Carosati, E; Cruciani, G; Fravolini, A; Kaatz, GW; Manfroni, G; Patel, D; Raygada, JL; Sabatini, S | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Bennis, K; Ducki, S; Lesage, F; Vivier, D | 1 |
2 review(s) available for chlorpromazine and flupenthixol
| Article | Year |
|---|---|
Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Chlorpromazine; Flupenthixol; Humans; Randomized Controlled Trials as Topic; Schizophrenia; Xerostomia | 2014 |
Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?
Topics: Arrhythmias, Cardiac; Depression; Epilepsy; Humans; Inflammation; Models, Molecular; Molecular Structure; Neuroprotective Agents; Pain; Potassium Channels, Tandem Pore Domain; Structure-Activity Relationship | 2016 |
4 trial(s) available for chlorpromazine and flupenthixol
| Article | Year |
|---|---|
Mechanism of the antipsychotic effect in the treatment of acute schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Flupenthixol; Humans; Isomerism; Male; Placebos; Receptors, Dopamine; Research Design; Schizophrenia; Thioxanthenes | 1978 |
Neuroendocrine changes in acute schizophrenia as a function of clinical state and neuroleptic medication.
Topics: Acute Disease; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Flupenthixol; Follicle Stimulating Hormone; Growth Hormone; Humans; Luteinizing Hormone; Orphenadrine; Prolactin; Receptors, Dopamine; Schizophrenia; Testosterone; Thioxanthenes | 1978 |
A double-blind comparison of fluphenazine decanoate and flupenthixol decanoate in the treatment of acute schizophrenia.
Topics: Acute Disease; Chlorpromazine; Clinical Trials as Topic; Drug Evaluation; Flupenthixol; Fluphenazine; Humans; Placebos; Schizophrenia; Time Factors | 1975 |
A randomised controlled trial of prophylactic neuroleptic treatment.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Female; Flupenthixol; Follow-Up Studies; Haloperidol; Humans; Male; Middle Aged; Pimozide; Random Allocation; Recurrence; Schizophrenia; Time Factors; Trifluoperazine | 1986 |
40 other study(ies) available for chlorpromazine and flupenthixol
| Article | Year |
|---|---|
Effect of flupenthixol and butaclamol isomers on prolactin secretion in rats.
Topics: Animals; Antipsychotic Agents; Chlorpromazine; Dibenzocycloheptenes; Flupenthixol; Haloperidol; Male; Prolactin; Quinolizines; Rats; Receptors, Dopamine; Stereoisomerism; Thioxanthenes | 1977 |
Effect of chlorpromazine and other anti-psychotic drugs on mouse striatal tyramines.
Topics: Animals; Antipsychotic Agents; Chlorpromazine; Corpus Striatum; Flupenthixol; Haloperidol; Male; Mice; Motor Activity; Structure-Activity Relationship; Tyramine | 1977 |
The effect of neuroleptic drugs on drinking induced by central administration of angiotensin or carbachol.
Topics: Angiotensin II; Animals; Antipsychotic Agents; Carbachol; Chlorpromazine; Clozapine; Dopamine; Drinking Behavior; Flupenthixol; Fluphenazine; Haloperidol; Injections, Intraperitoneal; Injections, Intraventricular; Male; Pimozide; Rats; Sulpiride | 1979 |
The effect of neuroleptic drugs on serum and cerebrospinal fluid melatonin concentrations in psychiatric subjects.
Topics: Adolescent; Adult; Age Factors; Aged; Antipsychotic Agents; Chlorpromazine; Female; Flupenthixol; Fluphenazine; Humans; Male; Melatonin; Mental Disorders; Middle Aged | 1979 |
Dopamine receptor blockade and the neuroleptics, a crystallographic study.
Topics: Chlorpromazine; Chlorprothixene; Crystallography; Dopamine Antagonists; Flupenthixol; Imipramine; Molecular Conformation; Phenothiazines; Promazine; Promethazine; Receptors, Drug; Structure-Activity Relationship; Thiethylperazine; Tranquilizing Agents; Triflupromazine | 1975 |
Comparison of the inhibitory effects of neuroleptic drugs on adenylate cyclase in rat tissues stimulated by dopamine, noradrenaline and glucagon.
Topics: Adenylyl Cyclase Inhibitors; Adipose Tissue; Animals; Chlorpromazine; Chlorprothixene; Corpus Striatum; Dopamine; Flupenthixol; Glucagon; Haloperidol; In Vitro Techniques; Liver; Membranes; Norepinephrine; Pimozide; Promazine; Rats; Receptors, Adrenergic; Tranquilizing Agents | 1976 |
The interaction of neuroleptic and muscarinic agents with central dopaminergic systems.
Topics: Adenylyl Cyclase Inhibitors; Animals; Apomorphine; Behavior, Animal; Chlorpromazine; Clopenthixol; Clozapine; Corpus Striatum; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Flupenthixol; Male; Methamphetamine; Models, Biological; Oxotremorine; Parasympathomimetics; Pimozide; Rats; Scopolamine; Substantia Nigra; Thioridazine; Tranquilizing Agents | 1975 |
Tardive dyskinesia presenting as severe dysphagia.
Topics: Bipolar Disorder; Chlorpromazine; Deglutition Disorders; Dyskinesia, Drug-Induced; Female; Flupenthixol; Humans; Middle Aged; Neurologic Examination; Substance Withdrawal Syndrome | 1992 |
Single-photon emission computerised tomography (SPECT) in schizophrenia.
Topics: Adult; Brain; Cerebrovascular Circulation; Chlorpromazine; Female; Flupenthixol; Humans; Schizophrenia; Temporal Lobe; Tomography, Emission-Computed, Single-Photon | 1990 |
Effect of calmidazolium (R24571) on histamine release from isolated rat mast cells.
Topics: Animals; Calcimycin; Calmodulin; Chlorpromazine; Flupenthixol; Glucose; Histamine Release; Imidazoles; Imipramine; In Vitro Techniques; Male; Mast Cells; p-Methoxy-N-methylphenethylamine; Rats; Rats, Inbred Strains; Trifluoperazine | 1986 |
Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortex.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Butyrophenones; Cerebral Cortex; Chlorpromazine; Clozapine; Dibenzazepines; Dibenzothiazepines; Down-Regulation; Flupenthixol; Kinetics; Loxapine; Male; Pyrimidinones; Rats; Rats, Inbred Strains; Receptors, Serotonin; Spiro Compounds; Time Factors | 1989 |
Two cases of agranulocytosis on addition of a butyrophenone to a long-standing course of phenothiazine treatment.
Topics: Agranulocytosis; Antipsychotic Agents; Chlorpromazine; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Droperidol; Drug Therapy, Combination; Female; Flupenthixol; Fluphenazine; Humans; Long-Term Care; Male; Middle Aged; Paranoid Disorders; Psychotic Disorders | 1989 |
Neuroleptic malignant syndrome: another medical cause of acute abdomen.
Topics: Abdomen, Acute; Adult; Chlorpromazine; Diagnostic Errors; Female; Flupenthixol; Humans; Intestinal Pseudo-Obstruction; Neuroleptic Malignant Syndrome; Sepsis; Tranquilizing Agents | 1989 |
Schizophrenia with good and poor outcome. I: Early clinical features, response to neuroleptics and signs of organic dysfunction.
Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Brain; Chlorpromazine; Cognition Disorders; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Prognosis; Prolactin; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Tomography, X-Ray Computed | 1985 |
Neuroleptic effects on platelet aggregation: a study in normal volunteers and schizophrenics.
Topics: Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Haloperidol; Humans; Male; Platelet Aggregation; Procyclidine; Schizophrenia; Sulpiride; Trifluoperazine | 1987 |
Personality diagnosis and illness diagnosis.
Topics: Adult; Bipolar Disorder; Borderline Personality Disorder; Chlorpromazine; Drug Therapy, Combination; Female; Flupenthixol; Hospitalization; Humans; Lithium; Lithium Carbonate; Personality Disorders; Schizotypal Personality Disorder | 1985 |
Pharmacological vs. clinical physiognomy of neuroleptics, with special reference to their sedative and antipsychotic effects.
Topics: Animals; Behavior, Animal; Chlorpromazine; Chlorprothixene; Clopenthixol; Dogs; Drug Evaluation, Preclinical; Drug Tolerance; Flupenthixol; Fluphenazine; Haloperidol; Mice; Motor Activity; Perphenazine; Rats; Tranquilizing Agents | 1974 |
The effects of SCH 23390, YM 09151-2, (+)- and (-)-3-PPP and some classical neuroleptics on D-1 and D-2 receptors in rat neostriatum in vitro.
Topics: 1-Methyl-3-isobutylxanthine; Acetylcholine; Animals; Antipsychotic Agents; Aporphines; Benzamides; Benzazepines; Caudate Nucleus; Chlorpromazine; Clozapine; Flupenthixol; Haloperidol; In Vitro Techniques; Male; Piperidines; Potassium; Putamen; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1984 |
Platelet monoamine oxidase activity in acute schizophrenia: relationship to symptomatology and neuroleptic medication.
Topics: Acute Disease; Blood Platelets; Chlorpromazine; Female; Flupenthixol; Humans; Male; Monoamine Oxidase; Schizophrenia; Sex Factors; Thioxanthenes | 1981 |
[A study on the pharmacological properties of atypical antipsychotic drugs: in vivo dopamine and serotonin receptor occupancy by atypical antipsychotic drugs in the rat brain].
Topics: Animals; Antipsychotic Agents; Autoradiography; Brain; Chlorpromazine; Clozapine; Dibenzothiepins; Flupenthixol; Haloperidol; In Vitro Techniques; Isoxazoles; Male; Piperidines; Pyrimidinones; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, Serotonin; Risperidone | 1993 |
Convulsions after enflurane in a schizophrenic patient receiving neuroleptics.
Topics: Adult; Anesthesia, Inhalation; Chlorpromazine; Drug Synergism; Enflurane; Epilepsy, Tonic-Clonic; Flupenthixol; Humans; Male; Schizophrenia; Seizures | 1994 |
Depot flupenthixol-induced mania.
Topics: Adult; Bipolar Disorder; Chlorpromazine; Delayed-Action Preparations; Flupenthixol; Humans; Lithium; Male | 1993 |
Phototoxic properties of neuroleptic drugs.
Topics: Antipsychotic Agents; Chlorpromazine; Chlorprothixene; Clopenthixol; Dermatitis, Phototoxic; Drug Eruptions; Erythrocytes; Flupenthixol; Fluphenazine; Hemolysis; Humans; Methotrimeprazine; Perazine; Perphenazine; Phenothiazines; Promazine; Promethazine; Radiation Dosage; Thiazines; Thioridazine; Thiothixene; Trifluoperazine; Triflupromazine; Ultraviolet Rays | 1997 |
The effects of dopamine receptor agonists and antagonists on the secretory rate of cockroach (Periplaneta americana) salivary glands.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analysis of Variance; Animals; Butaclamol; Chlorpromazine; Cockroaches; Dopamine Agonists; Dopamine Antagonists; Flupenthixol; Linear Models; Lisuride; Microscopy, Video; Proteins; Salivary Glands; Tetrahydronaphthalenes | 2004 |
The pharmacoepidemiology of antipsychotics for adults with schizophrenia in Canada, 2005 to 2009.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Canada; Chlorpromazine; Clopenthixol; Clozapine; Female; Flupenthixol; Humans; Loxapine; Male; Olanzapine; Pharmacoepidemiology; Schizophrenia | 2011 |
Intrathecal chlorprothixene, cis(z)-flupenthixol, chlorpromazine and fluphenazine for prolonged spinal blockades of sensory and motor functions in rats.
Topics: Anesthesia, Spinal; Anesthetics; Animals; Antipsychotic Agents; Behavior, Animal; Chlorpromazine; Chlorprothixene; Dopamine Antagonists; Flupenthixol; Fluphenazine; Injections, Spinal; Male; Nociception; Rats; Rats, Sprague-Dawley; Sensation | 2012 |
Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
Topics: Adenosine Monophosphate; Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chlorpromazine; Clopenthixol; Clozapine; Flupenthixol; Fluphenazine; Haloperidol; Humans; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Pimozide; Quetiapine Fumarate; Risperidone; Sulpiride; Trifluoperazine | 2022 |
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding, Competitive; Blotting, Northern; Brain; Cell Line; Cell Membrane; Cloning, Molecular; Dopamine; Humans; Kinetics; Molecular Sequence Data; Molecular Weight; Oligonucleotide Probes; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D5; RNA, Messenger; Sequence Homology, Nucleic Acid; Transfection | 1991 |
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
4-Piperazinyl-10H-thieno[2,3-b][1,5]benzodiazepines as potential neuroleptics.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Benzodiazepines; Body Temperature; Catalepsy; Humans; Lethal Dose 50; Mice; Piperazines; Rats; Structure-Activity Relationship | 1980 |
10-Piperazinyl-4H-theino[3,2-b][1,5]- and -[3,4-b][1,5]benzodiazepines as potential neuroleptics.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Benzodiazepines; Body Temperature; Catalepsy; Humans; Lethal Dose 50; Mice; Piperazines; Rats | 1980 |
Neuroleptic activity and dopamine-uptake inhibition in 1-piperazino-3-phenylindans.
Topics: Amphetamine; Animals; Antipsychotic Agents; Biological Assay; Biological Transport; Brain; Cell Membrane; Corpus Striatum; Dopamine; Haloperidol; Indans; Indenes; Male; Mice; Norepinephrine; Piperazines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Serotonin; Structure-Activity Relationship; Synaptosomes | 1983 |
Expression and pharmacological characterization of the human D3 dopamine receptor.
Topics: Animals; Binding, Competitive; Cells, Cultured; CHO Cells; Cricetinae; Dopamine; Dopamine Antagonists; GTP-Binding Proteins; Guanine Nucleotides; Humans; Potassium Channels; Rats; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Recombinant Proteins; Second Messenger Systems; Sulpiride | 1994 |
Molecular modeling of phenothiazines and related drugs as multidrug resistance modifiers: a comparative molecular field analysis study.
Topics: Antineoplastic Agents; Cell Survival; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Molecular Conformation; Phenothiazines; Thioxanthenes; Tumor Cells, Cultured | 1998 |
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Discovery of novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Benzimidazoles; Ciprofloxacin; Databases, Factual; Drug Resistance, Bacterial; Drug Synergism; Ethidium; Microbial Sensitivity Tests; Models, Molecular; Multidrug Resistance-Associated Proteins; Phenyl Ethers; Propanolamines; Quantitative Structure-Activity Relationship; Staphylococcus aureus; Structure-Activity Relationship; Sulfonamides | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |